Serum Institute If India

The Maharashtra government has told the Bombay High Court that it would provide security to Adar Poonawalla, CEO of the Serum Institute of India (SII) which manufacturers the Covishield vaccine against COVID-19, if he makes a request.

The efficacy of the Covishield vaccine goes up if the gap between two doses is more than 28 days, a top scientist at Adar Poonawalla's Serum Institute of India (SII) said today, a day before the launch of India's Covid vaccination drive.

Ahead of the COVID-19 vaccination drive that starts Saturday, Serum Institute of India, whose Covishield vaccine will be administered in the nationwide drive, has uploaded a fact sheet on its website to dispel doubts about its vaccine. The document addresses a wide range of frequently asked questions, including the risk and benefits of its vaccine ...

The Serum Institute of India's Covishield vaccine, which has got approval from the country's drug regulator, will be commercially available at Rs 1,000 per dose if the government allows sale in retail, company chief Adar Poonawalla has said.

Two vaccines for coronavirus, Oxford University's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the country's drug regulator on Sunday. "We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe," Drug Controller G...

Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.

Even if one goes around the world, vaccine for COVID-19 will be found only in Pune, NCP MP Supriya Sule said on Saturday, referring to Prime Minister Narendra Modi's visit to the Serum Institute of India (SII).

A minimum of 100 million doses of Covishield - a coronavirus vaccine that on Monday morning was said to be 90 per cent effective under certain conditions - will be available by January and hundreds of million could be ready by the end of February, Adar Poonawalla of the Serum Institute of India told NDTV.

Leading accounting and consultancy firm ernst & Young (E&Y) India has awarded the Tata Group patriarch Ratan Tata, the chairman Emeritus of the $100-billion conglomerate, with the entrepreneur of the year lifetime achievement award.

The Maharashtra government has told the Bombay High Court that it would provide security to Adar Poonawalla, CEO of the Serum Institute of India (SII) which manufacturers the Covishield vaccine against COVID-19, if he makes a request.

The efficacy of the Covishield vaccine goes up if the gap between two doses is more than 28 days, a top scientist at Adar Poonawalla's Serum Institute of India (SII) said today, a day before the launch of India's Covid vaccination drive.

Ahead of the COVID-19 vaccination drive that starts Saturday, Serum Institute of India, whose Covishield vaccine will be administered in the nationwide drive, has uploaded a fact sheet on its website to dispel doubts about its vaccine. The document addresses a wide range of frequently asked questions, including the risk and benefits of its vaccine ...

The Serum Institute of India's Covishield vaccine, which has got approval from the country's drug regulator, will be commercially available at Rs 1,000 per dose if the government allows sale in retail, company chief Adar Poonawalla has said.

Two vaccines for coronavirus, Oxford University's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the country's drug regulator on Sunday. "We'll never approve anything if there is slightest of safety concern. The vaccines are 110 per cent safe," Drug Controller G...

Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca, sources have said.

Even if one goes around the world, vaccine for COVID-19 will be found only in Pune, NCP MP Supriya Sule said on Saturday, referring to Prime Minister Narendra Modi's visit to the Serum Institute of India (SII).

A minimum of 100 million doses of Covishield - a coronavirus vaccine that on Monday morning was said to be 90 per cent effective under certain conditions - will be available by January and hundreds of million could be ready by the end of February, Adar Poonawalla of the Serum Institute of India told NDTV.

Leading accounting and consultancy firm ernst & Young (E&Y) India has awarded the Tata Group patriarch Ratan Tata, the chairman Emeritus of the $100-billion conglomerate, with the entrepreneur of the year lifetime achievement award.